from Reuters: U.S. https://ift.tt/2QXYFcb
Tuesday, 20 November 2018
Trial spotlights U.S. drug safety concerns at compounding pharmacies
A top U.S. Food and Drug Administration official testified on Monday that the agency has concerns about drugs made by compounding pharmacies and still sees problems with them six years after a fungal meningitis outbreak tied to a Massachusetts pharmacy killed 76 people.
from Reuters: U.S. https://ift.tt/2QXYFcb
from Reuters: U.S. https://ift.tt/2QXYFcb
Related Posts:
U.S. lawmakers want to tighten visas for Chinese students, researchers- Donald Trump Jr. agrees to Senate committee interview: source
- North Carolina 'bathroom bill' sponsor wins Republican nod for rerun of 2018 U.S. House race
- U.S. farmers receive $8.52 billion in aid to date, USDA says
- Search for victims ends after mid-air crash of Alaska tour planes; probe begins
0 comments:
Post a Comment